Pharmacokinetic studies of ginsenosides Rk1 and Rg5 in rats by UFLC–MS/MS

Authors:

Abstract
A rapid ultra‐fast liquid chromatography tandem mass spectrometry method was developed and validated to determine ginsenosides Rk1 and Rg5, a pair of isomers, in rat plasma, which was successfully applied to their pharmacokinetic studies. Two ginsenosides were given to male Sprague–Dawley rats via intragastrical and intravenous routes, respectively, and the impact of double bond position on the pharmacokinetic features of the two ginsenosides was elucidated in rats. Ginsenoside Rg3 was used as internal standard and ethyl acetate was applied to extract analytes and internal standard. Chromatographic separation was carried out on a reverse‐phase UPLC HSS T3 column (100 × 2.1 mm, 1.8 μm). The flow rate was set to 0.4 ml/min. The fragmentation transition was m/z 765.4 → m/z 101.1 for two ginsenosides. The mobile phases were composed of 0.1% formic acid aqueous solution and acetonitrile. The linear range was 2–1,000 ng/ml for the two ginsenosides. Intra‐ and inter‐day precisions were 20(22)‐ginsenosides showed better pharmacokinetic features than ∆20(21)‐ginsenosides with the same glycosylation.
Funding Information
  • National Natural Science Foundation of China (81903804, 81530101, 81530096)

This publication has 24 references indexed in Scilit: